Molecular Pharmaceutics
[ASAP] Evaluation of a CD206-Targeted Peptide for PET Imaging of Macrophages in Syngeneic Mouse Models of Cancer
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00977
Molecular Pharmaceutics
[ASAP] A Potential Boron Neutron Capture Therapy Agent Selectively Suppresses High-Grade Glioma: <italic toggle=”yes”>In Vitro</italic> and <italic toggle=”yes”>in Vivo</italic> Exploration
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00152
Molecular Pharmaceutics
[ASAP] Competitive Adsorption of a Monoclonal Antibody and Nonionic Surfactant at the PDMS/Water Interface
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01099
Molecular Pharmaceutics
[ASAP] Fast-Disintegrating Nanofibrous Web of Pullulan/Griseofulvin–Cyclodextrin Inclusion Complexes
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00074
Molecular Pharmaceutics
[ASAP] Synthesis and Preclinical Evaluation of a Novel FAPI-04 Dimer for Cancer Theranostics
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00965
Molecular Pharmaceutics
[ASAP] Development of an Amorphous Solid Dispersion Formulation for Mitigating Mechanical Instability of Crystalline Form and Improving Bioavailability for Early Phase Clinical Studies
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01056
Molecular Pharmaceutics
[ASAP] Noninvasive Assessment of Renal Fibrosis of Chronic Kidney Disease in Rats by [<sup>68</sup>Ga]Ga-FAPI-04 Small Animal PET/CT and Biomarkers
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00163
Molecular Pharmaceutics
[ASAP] Biopharmaceutical Modeling of Food EffectExploring the Role of Dietary Fat
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00170
Molecular Pharmaceutics
[ASAP] A Symbolic Regression Model for the Prediction of Drug Binding to Human Liver Microsomes
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01048
Molecular Pharmaceutics
[ASAP] Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic Acid
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00099